- In September 2024, Agilent announced the successful completion of its acquisition of BIOVECTRA, strengthening its contract development and manufacturing (CDMO) services. This acquisition expands Agilent's capabilities, particularly in gene editing, and enhances its ability to support advanced therapeutics programs. The move underscores Agilent's commitment to providing top-tier manufacturing solutions in the biotech sector
- In July 2021, STARLIMS Corporation entered into a definitive agreement with Francisco Partners to acquire the STARLIMS informatics product suite and related business assets from Abbott. This partnership is expected to strategically position STARLIMS for sustained growth and enhance its competitiveness in the market
- In April 2023, Microsoft and Epic expanded their partnership to integrate generative AI into healthcare by utilizing the Azure OpenAI Service alongside Epic's EHR software. This collaboration seeks to enhance healthcare productivity, improve patient care, and strengthen the financial stability of health systems across the globe. By combining advanced AI with Epic's software, the initiative aims to drive innovation in healthcare operations and patient outcomes
- In October 2024, Xybion launched LIMS 10.0, an advanced, AI-enabled solution designed to enhance laboratory efficiency across various industries. With an intuitive interface, integrated QMS, and powerful features such as inventory management and audit trails, LIMS 10.0 transforms laboratory operations, accelerating compliance and throughput on a global scale. This innovation aims to streamline processes, improve data accuracy, and support faster decision-making in laboratories worldwide
